GC Rieber VivoMega has announced a five-year $75 million investment plan to build a new facility at its manufacturing campus. The new facility will enable the company to more than double the output of its high-end triglyceride form of omega-3s EPA and DHA.
GC Rieber VivoMega (Norway) has announced a five-year $75 million investment plan to build a new facility at its manufacturing campus, with an anticipated completion date of early 2024. The new facility will enable the company to more than double the output of its high-end triglyceride form of omega-3s EPA and DHA.
“This investment is part of GC Rieber VivoMega’s continual commitment to develop the needed facilities for the increased capacity and production of our industry leading omega-3 oils,” said Jan Roger Bjerkestrand, managing director of GC Rieber VivoMega, in a press release. “To minimize our eco-footprint, we will be leveraging much of the existing infrastructure, including docks, tanks, laboratories, and energy to provide the same high-quality product that our customers are asking for.”
By the summer of 2022, GC Rieber VivoMega will complete the construction of a 32,000-metric ton tank park and updated technology platform in their existing manufacturing plants. The tank park enables the company to adjust to current supply chain challenges and is a key strategic asset to supporting the new expansion. Therefore, the new facility is also being designed with added flexibility to support future strategic growth areas in omega-3 high-end concentrates.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.